Identification of 4H,6H-[2]benzoxepino[4,5-c][1,2]oxazoles as novel squalene synthase inhibitors.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2011-06-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2011.04.092PMID 21576018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification and optimization of tetrahydro-2H-3-benzazepin-2-ones as squalene synthase inhibitors.

  2011cited by this paper
• Pharmacologic Inhibition of Squalene Synthase and Other Downstream Enzymes of the Cholesterol Synthesis Pathway: A New Therapeutic Approach to Treatment of Hypercholesterolemia

  2009cited by this paper
• Emerging lipid-lowering drugs: squalene synthase inhibitors.

  2008cited by this paper
• Emerging lipid-lowering drugs: squalene synthase inhibitors

  2008cited by this paper
• Lipid-lowering (hetero)aromatic tetrahydro-1,4-oxazine derivatives with antioxidant and squalene synthase inhibitory activity.

  2008cited by this paper
• Inhibition of the heat shock protein 90 molecular chaperone in vitro and in vivo by novel, synthetic, potent resorcinylic pyrazole/isoxazole amide analogues

  2007cited by this paper
• Drug evaluation: TAK-475--an oral inhibitor of squalene synthase for hyperlipidemia.

  2006cited by this paper
• Investigation of the scope of a [3+2] cycloaddition approach to isoxazole boronic esters

  2005cited by this paper
• Fragment screening and assembly: a highly efficient approach to a selective and cell active protein tyrosine phosphatase 1B inhibitor.

  2003cited by this paper
• The PyMOL Molecular Graphics System

  2002cited by this paper
• Syntheses of fused heterocyclic compounds and their inhibitory activities for squalene synthase.

  2002cited by this paper
• Novel 4,1-benzoxazepine derivatives with potent squalene synthase inhibitory activities.

  2002cited by this paper
• Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes.

  2000cited by this paper
• Crystal Structure of Human Squalene Synthase

  2000cited by this paper
• Morphological similarity: A 3D molecular similarity method correlated with protein-ligand recognition

  2000cited by this paper
• MMFF VI. MMFF94s option for energy minimization studies

  1999cited by this paper
• The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles.

  1998cited by this paper
• Hydrogen bonding properties of oxygen and nitrogen acceptors in aromatic heterocycles

  1997cited by this paper
• Oxygen and Nitrogen in Competitive Situations: Which is the Hydrogen‐Bond Acceptor?

  1996cited by this paper
• Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds

  1995cited by this paper
• New synthetic transformations via organoboron compounds

  1994cited by this paper
• Lipids and oxidised lipids in human atheroma and normal aorta.

  1993cited by this paper
• Peralkylated Polyaminophosphazenes— Extremely Strong, Neutral Nitrogen Bases

  1987cited by this paper
• Determination of free, total, and esterified cholesterol by high-performance liquid chromatography.

  1979cited by this paper
• Über Triphenyl‐phosphin‐methylene als olefinbildende Reagenzien (I. Mitteil.

  1954cited by this paper

• Exploring the Reactivity of Substituted [(Allyloxy)methyl]phosphonates in Cycloaddition and Coupling Reactions

  2023cites this paper
• Effect of a new squalene synthase inhibitor on an ApoE-/- mouse model of atherosclerosis.

  2023cites this paper
• Synthesis of 3-Borylated Pyrrolidines by 1,3-Dipolar Cycloaddition of Alkenyl Boronates and Azomethine Ylide.

  2022cites this paper
• A comprehensive review on biological activities of oxazole derivatives

  2019cites this paper
• Identification of hit compounds for squalene synthase: Three‐dimensional quantitative structure‐activity relationship pharmacophore modeling, virtual screening, molecular docking, binding free energy calculation, and molecular dynamic simulation

  2017cites this paper
• A one-pot synthesis of indole-appended heterocycles as potent anti-inflammatory, analgesic, and CNS depressant agents

  2015cites this paper
• DIFFERENT CHEMICAL, BIOLOGICAL AND MOLECULAR APPROACHES FOR ANTI-HYPERLIPIDEMIC THERAPY WITH SPECIAL EMPHASIS ON ANTI-HYPERLIPIDEMIC AGENTS OF NATURAL ORIGIN

  2014cites this paper
• Design of novel potent antihyperlipidemic agents with antioxidant/anti-inflammatory properties: exploiting phenothiazine's strong antioxidant activity.

  2014cites this paper
• Molecular Docking Studies of Squalen Synthase Inhibitors as Potential Anti Cardiovascular Disease Drugs: Insights into Drug-Protein Interaction Discovery

  2013cites this paper
• Discovery of DF-461, a Potent Squalene Synthase Inhibitor.

  2013cites this paper
• Discovery of novel tricyclic compounds as squalene synthase inhibitors.

  2012cites this paper
• Novel LDL-oriented pharmacotherapeutical strategies.

  2012cites this paper